122 related articles for article (PubMed ID: 15384773)
1. [A chronic infection with long-term treatment].
Grivois JP; Bricaire F
Soins; 2004; (687):36-9. PubMed ID: 15384773
[No Abstract] [Full Text] [Related]
2. Antiretroviral treatment in HIV infection.
Raines CP
Lippincotts Prim Care Pract; 2000; 4(1):83-100. PubMed ID: 11022522
[No Abstract] [Full Text] [Related]
3. HIV therapeutics: points from the recent literature.
Laurence J
AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
[No Abstract] [Full Text] [Related]
4. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
5. Monitoring treatment: at what cost?
Cohen J
Science; 2004 Jun; 304(5679):1936. PubMed ID: 15218140
[No Abstract] [Full Text] [Related]
6. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
[No Abstract] [Full Text] [Related]
7. Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials).
Durier C; Capitant C; Lascaux AS; Goujard C; Oksenhendler E; Poizot-Martin I; Viard JP; Weiss L; Netzer E; Delfraissy JF; Aboulker JP; Lévy Y
AIDS; 2007 Sep; 21(14):1887-97. PubMed ID: 17721096
[TBL] [Abstract][Full Text] [Related]
8. Drug news.
Huff B
GMHC Treat Issues; 2004; 18(9-10):13-5. PubMed ID: 15619787
[No Abstract] [Full Text] [Related]
9. [Epidemiology, physiopathology and therapeutic modalities of HIV infections].
Belan AG
Soins; 2009 Apr; (734):32-5. PubMed ID: 19475824
[No Abstract] [Full Text] [Related]
10. HIV disease management: new technologies improve outcomes and contain costs.
Valenti WM
AIDS Read; 2002 Feb; 12(2):64-6. PubMed ID: 11905142
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for kidney transplantation in patients with HIV disease.
Bhagani S; Sweny P; Brook G;
HIV Med; 2006 Apr; 7(3):133-9. PubMed ID: 16494626
[No Abstract] [Full Text] [Related]
13. Consensus statement on long-term effectiveness research.
Women Alive; 2000; ():9. PubMed ID: 11682997
[No Abstract] [Full Text] [Related]
14. Anti-HIV agents. How long will a first regimen last?
TreatmentUpdate; 2003; 15(5):1-2. PubMed ID: 17219614
[No Abstract] [Full Text] [Related]
15. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V
J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973
[TBL] [Abstract][Full Text] [Related]
16. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
[TBL] [Abstract][Full Text] [Related]
17. Current status of HIV infection: a review for non-HIV-treating physicians.
Knoll B; Lassmann B; Temesgen Z
Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
[TBL] [Abstract][Full Text] [Related]
18. High rate of misclassification of treatment failure based on WHO immunological criteria.
Castelnuovo B; Kiragga A; Schaefer P; Kambugu A; Manabe Y
AIDS; 2009 Jun; 23(10):1295-6; author reply 1296. PubMed ID: 19509481
[No Abstract] [Full Text] [Related]
19. Long-term safety study of vicriviroc presented.
Proj Inf Perspect; 2008 Dec; (47):13. PubMed ID: 19227564
[No Abstract] [Full Text] [Related]
20. Anti-HIV agents. Receptor blocker (SCH 532706) enters clinical trials.
TreatmentUpdate; 2008 Mar; 20(2):8-9. PubMed ID: 18663778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
